Covered Call Analyzer Conservative "STOCKS-TO-CONSIDER"
|
Company Name |
Stock Symbol |
Stock Price |
# of shares |
Total Cost* |
Option Symbol |
Sep Option Price |
Income from sale* |
Strike Price |
Projected return if Called after one month* |
Actual $ return* |
Actual % Return* |
| American Pharma. | APPX | $37.65 | 200 | $7,550 | AQOAT | $1.35 | $250 | 47.5 | 28% | +$2,200 | +28% |
| Comments: |
Called |
||||||||||
| American Pharma. | APPX | $37.65 | 200 | $7,550 | AQOAI | $1.90 | $360 | 45 | 23% | +$1,810 | +23% |
| Comments: |
Called. |
||||||||||
|
Vimpel-Comm. |
VIP |
$29.51 |
300 |
$8,873 |
VIPAG |
$1.35 |
$385 |
35 |
22% |
+$1,543 |
+17% |
|
Comments: |
Not called. Sold all shares at $33.37 to close out position. |
||||||||||
| Netflix, Inc. | NFLX | $12.98 | 700 | $9,106 | QNQAC | $0.50 | $330 | 15 | 18% | ($1,028) | -11% |
| Comments: |
Not called. Sold all shares at $11.04 to close out position. |
||||||||||
| Vimpel-Comm. | VIP | $29.51 | 300 | $8,873 | VIPAV | $1.85 | $535 | 33.38 | 18% | +$1,693 | +19% |
| Comments: |
Not called. Sold all shares at $33.37 to close out position. |
||||||||||
|
Ask Jeeves, Inc. |
ASKJ |
$26.38 | 300 | $7,934 | AUKAF | $0.65 | $185 | 30 | 15% | +$367 | +5% |
| Comments: |
Not called. Sold all shares at $27.02 to close out position. |
||||||||||
|
American Pharma. |
APPX |
$37.65 |
200 |
$7,550 |
AQOAH |
$3.70 |
$720 |
40 |
15% |
+$1,170 | +15% |
| Comments: |
Called. |
||||||||||
|
Vimpel-Comm. |
VIP | $29.51 | 300 | $8,873 | VIPAU | $2.35 | $685 | 31.63 | 14% | +$1,301 | +14% |
| Comments: |
Called. |
||||||||||
|
Sina Corp. |
SINA | $31.75 | 300 | $9,545 | NOQAG | $1.30 | $370 | 35 | 14% | ($1,205) | -13% |
| Comments: |
Exercised get-out price at $26.99 after buying back calls at 0.42. |
||||||||||
|
IVAX Corp. |
IVX |
$15.73 | 600 | $9,458 | IVXAW | $0.45 | $250 | 17.5 | 13% | ($560) | -6% |
| Comments: |
Not called. Sold all shares at $14.38 to close out position. |
||||||||||
|
All positions closed out with protfolio value up +$7,292. |
|||||||||||
*After the effect of all commissions.
The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.